Our negativeKRAS/BRAF results are similar to the negativefindings of another study which tested chordomas for KRAS andBRAF mutations and their relationship with theFGFR-RAS/RAF/MEK/ERK-ETS2/brachyury pathway [32]. This evidence concerns the gene MAP2K7 and chordoma.